Medical Facilities Corporation
TSX:DR.TO · Toronto Stock Exchange
+$0.18 today
Vol 0.01M · Avg 0.02M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
TSX:DR.TO · Revenue to Net Income
Key Ratios
Analysis
$305.4M of revenue converted into $26.0M of net income for the selected period. Gross margin is 44.3% and net margin is 8.6%, showing how much revenue survives after costs and taxes. EPS is $1.76, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $258.6M -22.0% | $331.5M -25.6% | $445.6M +5.0% | $424.6M +6.5% | $398.6M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $160.4M +43.7% | $111.6M -25.0% | $148.9M +3.5% | $143.9M +10.7% | $130.0M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $98.2M -55.3% | $219.9M -25.9% | $296.7M +5.7% | $280.6M +4.5% | $268.6M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 38.0% -28.4pp | 66.3% -0.3pp | 66.6% +0.5pp | 66.1% -1.3pp | 67.4% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $119.2M -21.1% | $151.1M -0.4% | $151.7M -23.5% | $198.2M +11.6% | $177.6M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $50.7M -67.9% | $158.2M -31.1% | $229.6M -6.6% | $245.7M +28.5% | $191.2M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $11.9M -38.4% | $19.4M -10.1% | $21.5M +3.7% | $20.8M -22.4% | $26.8M | $374.2M | $1.2B | $631.8M |
| EBITDA | $59.4M -28.1% | $82.6M +14.0% | $72.4M +41.6% | $51.2M -50.5% | $103.4M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 23.0% -1.9pp | 24.9% +8.7pp | 16.3% +4.2pp | 12.0% -13.9pp | 25.9% | 5.6% | 46.3% | 42.0% |
| Operating Income | $47.5M -23.0% | $61.6M -8.2% | $67.1M +92.1% | $34.9M -54.8% | $77.4M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 18.4% -0.2pp | 18.6% +3.5pp | 15.1% +6.8pp | 8.2% -11.2pp | 19.4% | 16.6% | 24.1% | 22.0% |
| Interest Income | $2.2M +20.2% | $1.9M +160.4% | $717.0K -91.6% | $8.5M +11140.8% | $76.0K | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $3.6M -70.3% | $12.1M -26.7% | $16.5M +28.1% | $12.9M -49.9% | $25.7M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$7.2M +31.7% | -$10.5M +26.2% | -$14.3M +18.2% | -$17.4M +34.1% | -$26.5M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $40.3M -21.2% | $51.1M -2.3% | $52.3M +198.9% | $17.5M -65.6% | $50.9M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 15.6% +0.2pp | 15.4% +3.7pp | 11.7% +7.6pp | 4.1% -8.6pp | 12.8% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $5.1M +189.0% | -$5.7M -168.3% | $8.3M +59.9% | $5.2M +18.5% | $4.4M | $1.3B | -$1.6B | $745.2M |
| Net Income | $21.1M -71.3% | $73.5M +297.2% | $18.5M +520.0% | -$4.4M -128.4% | $15.5M | $4.9B | $4.8B | $4.7B |
| Net Margin | 8.2% -14.0pp | 22.2% +18.0pp | 4.2% +5.2pp | -1.0% -4.9pp | 3.9% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $1 +5.8% | $1 +41.1% | $1 +73.8% | $0 -72.0% | $2 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $1 +5.8% | $1 +41.1% | $1 +73.8% | $0 -71.8% | $1 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $19.5M +5.3% | $18.5M -27.0% | $25.3M -13.7% | $29.4M -5.6% | $31.1M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $19.5M -18.8% | $24.0M -5.0% | $25.3M -14.0% | $29.4M -5.7% | $31.1M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
NervGen Pharma Corp.
NGEN.V
$407.94M
Fennec Pharmaceuticals Inc.
TSX:FRX.TO
$360.97M
Eupraxia Pharmaceuticals Inc.
TSX:EPRX.TO
$324.88M
Profound Medical Corp.
TSX:PRN.TO
$285.95M
TerrAscend Corp.
TSX:TSND.TO
$283.25M
Auxly Cannabis Group Inc.
TSX:XLY.TO
$250.54M
Canopy Growth Corporation
TSX:WEED.TO
$245.35M
CareRx Corporation
TSX:CRRX.TO
$203.03M
OrganiGram Holdings Inc.
TSX:OGI.TO
$188.33M
Cybin Inc.
CYBN.NE
$154.92M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does DR.TO generate?
Medical Facilities Corporation (DR.TO) reported $258.62M of revenue in fiscal 2025.
Is DR.TO profitable?
Medical Facilities Corporation (DR.TO) reported $21.08M of net income, with a net margin of 8.2%.
Explore More
Continue the stock analysis
Jump to another research area for this company.